In the latest trading session, 1.07 million Clearmind Medicine Inc (NASDAQ:CMND) shares changed hands as the company’s beta touched -1.73. With the company’s most recent per share price at $0.12 changing hands around $0.0 or -3.36% at last look, the market valuation stands at $1.68M. CMND’s current price is a discount, trading about -4983.33% off its 52-week high of $6.10. The share price had its 52-week low at $0.11, which suggests the last value was 8.33% up since then. When we look at Clearmind Medicine Inc’s average trading volume, we note the 10-day average is 0.82 million shares, with the 3-month average coming to 2.06 million.
Clearmind Medicine Inc (NASDAQ:CMND) trade information
Instantly CMND was in red as seen in intraday trades today. With action -12.55%, the performance over the past five days has been red. The drop to weekly highs of 0.1380 on Monday, 11/20/23 subtracted -3.36% to the stock’s daily price. The company’s shares are showing year-to-date downside of -96.36%, with the 5-day performance at -12.55% in the red. However, in the 30-day time frame, Clearmind Medicine Inc (NASDAQ:CMND) is -21.02% down. Looking at the short shares, we see there were 0.32 million shares sold at short interest cover period of 0.07 days.
Clearmind Medicine Inc (NASDAQ:CMND)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 7.43% of Clearmind Medicine Inc shares while 3.14% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 3.39%. There are 3.14% institutions holding the Clearmind Medicine Inc stock share, with AdvisorShares Investments, LLC the top institutional holder. As of Jun 29, 2023, the company held 4.95% of the shares, roughly 0.12 million CMND shares worth $58547.0.
Geode Capital Management, LLC holds the second largest percentage of outstanding shares, with 2.07% or 51523.0 shares worth $24473.0 as of Jun 29, 2023.
Among Mutual Funds, the top two as of Sep 29, 2023 were AdvisorShares Trust-AdvisorShares Psychedelics ETF and Fidelity NASDAQ Composite Index ETF. With 0.12 million shares estimated at $19721.0 under it, the former controlled 4.95% of total outstanding shares. On the other hand, Fidelity NASDAQ Composite Index ETF held about 2.55% of the shares, roughly 63564.0 shares worth around $10170.0.